UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007692
Receipt number R000009072
Scientific Title Open trial of papaverine for treatment-resistant schizophrenia
Date of disclosure of the study information 2012/04/08
Last modified on 2013/07/14 05:42:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Open trial of papaverine for treatment-resistant schizophrenia

Acronym

Papaverine Open Trial

Scientific Title

Open trial of papaverine for treatment-resistant schizophrenia

Scientific Title:Acronym

Papaverine Open Trial

Region

Japan


Condition

Condition

Treatment-resistant schizophrenia

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To test whether additional administration of papaverine can be clinically useful for the patients with treatment-resistant schizophrenia.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Change of PANSS score.

Key secondary outcomes

Change of DIEPSS score.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Additional administration of papaverine.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with Treatment-resistant schizophrenia.

Key exclusion criteria

Patients who are supposed to be in danger with papaverine.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masaomi Iyo

Organization

Chiba-university Hospital

Division name

Department of Psychiatry

Zip code


Address

1-8-1 Inohana, Chiba 260-8670, Japan

TEL

043-222-7171

Email



Public contact

Name of contact person

1st name
Middle name
Last name Shigenori Tadokoro

Organization

Chiba-university Hospital

Division name

Department of Psychiatry

Zip code


Address


TEL


Homepage URL


Email

tadokoroshigenori@gmail.com


Sponsor or person

Institute

Chiba-university Hospital

Institute

Department

Personal name



Funding Source

Organization

Chiba University Graduate School of Medicine, Chiba, Japan

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 04 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2011 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 04 Month 01 Day

Last follow-up date

2013 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 04 Month 08 Day

Last modified on

2013 Year 07 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009072


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name